LLMpediaThe first transparent, open encyclopedia generated by LLMs

Cochrane Collaboration

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Expansion Funnel Raw 83 → Dedup 21 → NER 15 → Enqueued 10
1. Extracted83
2. After dedup21 (None)
3. After NER15 (None)
Rejected: 6 (not NE: 6)
4. Enqueued10 (None)
Similarity rejected: 6
Cochrane Collaboration
NameCochrane Collaboration
Formation1993
FounderIain Chalmers; Alan D. Q. Hunter
TypeNon-profit organization
HeadquartersLondon
Region servedGlobal

Cochrane Collaboration The Cochrane Collaboration is an international network of researchers, clinicians, patients and policy-makers that produces systematic reviews of healthcare interventions to inform decision-making. Founded in the early 1990s alongside movements in evidence-based medicine such as those led by Iain Chalmers and institutions like the Cochrane Library predecessor initiatives, it has influenced organizations including the World Health Organization, National Institute for Health and Care Excellence, Centers for Disease Control and Prevention, European Medicines Agency and United States Preventive Services Task Force. Its work intersects with major projects and figures such as James Lind Alliance, Evidence-Based Medicine Working Group, David Sackett, John Ioannidis and BMJ-linked trials and guidelines. The Collaboration is known for methodologies overlapping with standards from the CONSORT statement, GRADE working group and reporting systems used by PubMed and EMBASE.

History

The organisation emerged from debates at meetings such as the Cochrane Colloquium and proposals informed by trials registries championed in forums like the James Lind Initiative, and drew on methods developed in clinical epidemiology units at the University of Oxford, McMaster University, King's College London and Johns Hopkins University. Early contributors included figures associated with the Cochrane Centre network, academic departments at University of Toronto and policy units in World Health Organization headquarters. Growth paralleled expansions in electronic databases like MEDLINE and The Cochrane Library while responding to controversies tied to landmark events such as the Thalidomide saga and regulatory changes after the HIV/AIDS crisis. Over decades it established regional centers and editorial groups in places from Australia and Canada to South Africa and Spain.

Organization and governance

The Collaboration operates through a federated structure of editorial groups, review groups, networks and regional centers linked to institutions such as Oxford University Press, Wiley-Blackwell, the European Commission stakeholders and national health agencies like NHS England and Public Health Agency of Canada. Governance is directed by a board and executive informed by advisory panels and stakeholder constituencies, engaging with professional societies including the Royal College of Physicians, American Medical Association, European Society of Cardiology and consumer organisations like Healthwatch and patient advocacy groups tied to Alzheimer's Society and Cancer Research UK. Financial and legal frameworks interact with funders such as the Bill & Melinda Gates Foundation, national research councils including the National Institutes of Health and foundations associated with Wellcome Trust and European Research Council.

Methods and standards

Cochrane methods incorporate systematic search strategies across databases including MEDLINE, Embase, ClinicalTrials.gov and CENTRAL, using bias assessment tools influenced by work from Jadad and frameworks like GRADE and CONSORT. Protocols and review conduct follow policies developed with input from methodologists at McMaster University, University of Oxford, Karolinska Institutet and statisticians connected to Cochrane Methods Group and trialists from trials in Lancet and The New England Journal of Medicine. The standards address randomized controlled trials, observational studies, diagnostic test accuracy and network meta-analysis, referencing software and initiatives such as RevMan, GRADEpro and standards from the International Committee of Medical Journal Editors.

Cochrane Reviews and publications

Cochrane Reviews synthesise evidence across topics ranging from cardiology guidelines influenced by European Society of Cardiology trials to oncology interventions evaluated in trials published in Journal of Clinical Oncology and Annals of Internal Medicine. Reviews are archived in repositories comparable to The Cochrane Library and indexed by services like PubMed and citation databases such as Web of Science and Scopus. The organisation also issues rapid responses for outbreaks similar to work by World Health Organization during epidemics like Ebola virus epidemic in West Africa and pandemics such as COVID-19 pandemic, collaborating with guideline developers at NICE and health technology assessment agencies like National Institute for Health and Care Excellence and Institut national de la santé et de la recherche médicale.

Partnerships and advocacy

Cochrane partners with international bodies including World Health Organization, UNICEF, European Commission health units and research funders such as the Wellcome Trust and Bill & Melinda Gates Foundation. It engages with professional associations like the Royal College of Physicians and research networks at Global Health Network and supports capacity building through collaborations with universities such as University of Cape Town, Monash University and University of Sao Paulo. Advocacy work touches on open access movements represented by groups like SPARC and aligns with data sharing initiatives such as AllTrials and trial registration reforms championed in forums like ICMJE meetings.

Criticisms and controversies

The Collaboration has faced critiques concerning editorial conflicts of interest tied to funding from stakeholders like pharmaceutical companies referenced in disputes involving regulatory scrutiny from agencies such as the European Medicines Agency, methodological debates with researchers like John Ioannidis, and internal governance disputes reported in media outlets such as The Guardian and The Lancet. Controversies have included disagreements over review updating frequency, handling of retracted trials similar to cases in Committee on Publication Ethics investigations, and debates about neutrality when interacting with bodies like WHO or national agencies such as NHS England. Reforms have been pursued with oversight from panels drawing on expertise from institutions including Harvard Medical School, Stanford University and legal advisors linked to international nonprofit regulation.

Category:Medical and health organisations